Tie2-binding agents and methods of use
US-2024327528-A1 · Oct 3, 2024 · US
This page is not indexed by search engines while we improve data quality.
Hass Philip E patents
Hass Philip E is listed as an inventor on 42 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hass Philip E |
| Total patents | 42 |
| First publication | Jan 21, 2016 |
| Latest publication | Oct 3, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Tie2-binding agents and methods of use
US-11999787-B2 · Jun 4, 2024 · US
Anti-interleukin-33 antibodies and uses thereof
US-11725050-B2 · Aug 15, 2023 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2023063741-A1 · Mar 2, 2023 · US
IL-22 Fc fusion proteins
US-11332507-B2 · May 17, 2022 · US
Tie2-binding agents and methods of use
US-2021332142-A1 · Oct 28, 2021 · US
Methods of treating acute pancreatitis using IL-22 fc fusion proteins
US-11155591-B2 · Oct 26, 2021 · US
Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins
US-11136365-B2 · Oct 5, 2021 · US
Methods for treating metabolic syndrome using IL-22 Fc fusion proteins
US-11130791-B2 · Sep 28, 2021 · US
Anti-factor D antibody variant conjugates and uses thereof
US-10961313-B2 · Mar 30, 2021 · US
Recent patents
Latest publications not already listed above.
Anti-interleukin-33 antibodies and uses thereof
US-2021002361-A1 · Jan 7, 2021 · US
Il-17a/f heterologous polypeptides and therapeutic uses thereof
US-2020385452-A1 · Dec 10, 2020 · US
Il-17a/f heterologous polypeptides and therapeutic uses thereof
US-2020377585-A1 · Dec 3, 2020 · US
Anti-interleukin-33 antibodies and uses thereof
US-10723795-B2 · Jul 28, 2020 · US
Anti-factor D antibody variant conjugates and uses thereof
US-10654932-B2 · May 19, 2020 · US
Anti-factor d antibody variant conjugates and uses thereof
US-2020115462-A1 · Apr 16, 2020 · US
Pharmaceutical compositions of IL-22 Fc fusion proteins
US-10584155-B2 · Mar 10, 2020 · US
Methods of accelerating or improving wound healing using IL-22 FC fusion proteins
US-10544198-B2 · Jan 28, 2020 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019233491-A1 · Aug 1, 2019 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019177388-A1 · Jun 13, 2019 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019177386-A1 · Jun 13, 2019 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019177390-A1 · Jun 13, 2019 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019177387-A1 · Jun 13, 2019 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2019177389-A1 · Jun 13, 2019 · US
Il-17a/f heterologous polypeptides and therapeutic uses thereof
US-2019100583-A1 · Apr 4, 2019 · US
Anti-interleukin-33 antibodies and uses thereof
US-2019092852-A1 · Mar 28, 2019 · US
Anti-factor D antibodies
US-10179821-B2 · Jan 15, 2019 · US
Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins
US-10160793-B2 · Dec 25, 2018 · US
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
US-2018362608-A1 · Dec 20, 2018 · US
IL-22 Fc FUSION PROTEIN AND METHODS OF USE
US-2018355009-A1 · Dec 13, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genentech Inc | 42 |
| Novartis Pharma Ag | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.